Literature DB >> 23912605

Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas.

Felice Giuliante1, Agostino Maria De Rose, Vito Guerra, Francesco Ardito, Gennaro Nuzzo, Brian I Carr.   

Abstract

PURPOSE: Large hepatocellular carcinoma (HCC) presents on cirrhosis or in the absence of cirrhosis. Prognostic factors include both tumor and liver factors. Evaluate clinical and tumor characteristics of a group of large resected HCC in European patients.
METHODS: Data for patients with HCC >7 cm who underwent liver resection between 1992 and 2011 were analyzed. Patients were dichotomized into those with tumor diameters of 7-10 cm or >10 cm and their characteristics and outcomes were compared.
RESULTS: A total of 65 hepatectomies for HCC ≥7 cm were performed. Severe fibrosis or cirrhosis was present in 41.5 % of patients. Thirty-seven (56.9 %) patients had HCC ≥10 cm. Mortality and morbidity rates were 1.5 % and 37.5 %, respectively. Preoperative blood platelet levels and serum alkaline phosphatase (ALKP) levels showed significant differences between the groups. The 3-year survival was 43.5 % and 17.4 % for patients with tumors 7-10 and ≥10 cm, respectively.
CONCLUSIONS: Patients with large size HCC and preserved liver function can be resected with low operative risk. ALKP levels and platelet counts were higher in the larger tumors. Given these patterns of clinical and biochemical characteristics, this group of tumors may be a selected subset of large HCCs and might potentially benefit from surgical resection.

Entities:  

Mesh:

Year:  2013        PMID: 23912605     DOI: 10.1007/s12029-013-9523-5

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  44 in total

1.  Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma.

Authors:  Jean S Campbell; Steven D Hughes; Debra G Gilbertson; Thomas E Palmer; Matthew S Holdren; Aaron C Haran; Melissa M Odell; Renay L Bauer; Hong-Ping Ren; Harald S Haugen; Matthew M Yeh; Nelson Fausto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

2.  Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus.

Authors:  J Zhou; Z Y Tang; J Fan; Z Q Wu; X M Li; Y K Liu; F Liu; H C Sun; S L Ye
Journal:  J Cancer Res Clin Oncol       Date:  2000-01       Impact factor: 4.553

3.  Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.

Authors:  Sheng-Nan Lu; Jing-Houng Wang; Shiann-Long Liu; Chao-Hung Hung; Chien-Hung Chen; Hung-Da Tung; Tsung-Ming Chen; Wu-Shiung Huang; Chuan-Mo Lee; Chia-Cheng Chen; Chi-Sin Changchien
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

Review 4.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

5.  Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma?

Authors:  Giovanni Ramacciato; Paolo Mercantini; Niccolò Petrucciani; Matteo Ravaioli; Alessandro Cucchetti; Massimo Del Gaudio; Matteo Cescon; Vincenzo Ziparo; Antonio Daniele Pinna
Journal:  Am Surg       Date:  2010-11       Impact factor: 0.688

6.  Efficacy of major hepatectomy for large hepatocellular carcinoma.

Authors:  Atsushi Miyoshi; Tomohide Takahashi; Takao Otsuka; Naohiko Kohya; Kohji Miyazaki
Journal:  Hepatogastroenterology       Date:  2009 May-Jun

7.  Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.

Authors:  Lian-Yue Yang; Feng Fang; Di-Peng Ou; Wei Wu; Zhi-Jun Zeng; Fan Wu
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

8.  Chinese experience with hepatectomy for huge hepatocellular carcinoma.

Authors:  X P Chen; F Z Qiu; Z D Wu; B X Zhang
Journal:  Br J Surg       Date:  2004-03       Impact factor: 6.939

9.  Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection.

Authors:  S Truant; E Boleslawski; A Duhamel; A-F Bouras; A Louvet; C Febvay; E Leteurtre; G Huet; P Zerbib; S Dharancy; M Hebbar; F-R Pruvot
Journal:  Eur J Surg Oncol       Date:  2012-08-03       Impact factor: 4.424

10.  Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.

Authors:  F Trevisani; P E D'Intino; P Caraceni; M Pizzo; G F Stefanini; A Mazziotti; G L Grazi; G Gozzetti; G Gasbarrini; M Bernardi
Journal:  Cancer       Date:  1995-05-01       Impact factor: 6.860

View more
  2 in total

1.  HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection.

Authors:  Valeria Abbate; Margherita Marcantoni; Felice Giuliante; Fabio M Vecchio; Ilaria Gatto; Caterina Mele; Antonio Saviano; Damiano Arciuolo; Eleonora Gaetani; Maria C Ferrari; Igor Giarretta; Francesco Ardito; Laura Riccardi; Alberto Nicoletti; Francesca R Ponziani; Antonio Gasbarrini; Maurizio Pompili; Roberto Pola
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

2.  Transcatheter arterial chemoembolization monotherapy vs combined transcatheter arterial chemoembolization-percutaneous microwave coagulation therapy for massive hepatocellular carcinoma (≥10 cm).

Authors:  Yanyan Wei; Feng Dai; Tianhui Zhao; Chen Tao; Lili Wang; Wei Ye; Wei Zhao
Journal:  Cancer Manag Res       Date:  2018-11-01       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.